Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples.
about
Potential role for interleukin-10 in the immunosuppression associated with kala azarImpact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritisIL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritisCytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: implications for rheumatoid arthritisActive suppression induced by repetitive self-epitopes protects against EAE developmentTreatment with interleukin 12 in combination with atovaquone or clindamycin significantly increases survival of mice with acute toxoplasmosisLocal and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaBModulation of allergic inflammation in mice deficient in TNF receptors.Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis.Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice.Paclitaxel (Taxol)-induced killing of Leishmania major in murine macrophages.Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits.An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammationChimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cellsSpecies-specific inhibition of cerebral malaria in mice coinfected with Plasmodium spp.Identification of amino acid residues of the T-cell epitope of Mycobacterium tuberculosis alpha antigen critical for Vbeta11(+) Th1 cells.The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis.Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae.Adoptive immunotherapy with Cl-IB-MECA-treated CD8+ T cells reduces melanoma growth in miceSimilar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B.IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesisInterleukin 10 reduces mortality from severe peritonitis in miceIdentification of markers that distinguish IgE- from IgG-mediated anaphylaxis.Dysregulated production of interleukin-10 (IL-10) and IL-12 by peripheral blood lymphocytes from human immunodeficiency virus-infected individuals is associated with altered proliferative responses to recall antigens.Persistence of local cytokine production in shigellosis in acute and convalescent stages.Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis.Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in miceInterleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia.Acquired resistance against a secondary infection with Listeria monocytogenes in mice is not dependent on reactive nitrogen intermediatesActivation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in miceRegulation of parasite antigen-driven immune responses by interleukin-10 (IL-10) and IL-12 in lymphatic filariasis.Systemic infection of mice by wild-type but not Spv- Salmonella typhimurium is enhanced by neutralization of gamma interferon and tumor necrosis factor alpha.Critical involvement of extracellular ATP acting on P2RX7 purinergic receptors in photoreceptor cell death.Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology.Preferential activation and expansion of human peripheral blood gamma delta T cells in response to Toxoplasma gondii in vitro and their cytokine production and cytotoxic activity against T. gondii-infected cells.Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major.Oral administration of antigen does not influence the proliferation and IFN-γ production of responsive CD8+ T cells but enables to establish T cell clones with different lymphokine production profile.Interleukin 5 induces S mu-S gamma 1 DNA rearrangement in B cells activated with dextran-anti-IgD antibodies and interleukin 4: a three component model for Ig class switching.Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras
P2860
Q24594397-8CDB06F5-C171-44B1-B40D-CDBFDEA49213Q24795258-FF474F08-E4D3-4CC7-ABCC-7002EEF5EB8FQ24796707-BA7E393D-7249-4BD4-A5A2-CB5D76D86DDFQ24800148-80E368F1-9008-4C8D-9459-594260C1E098Q27318065-733EB727-F20A-4632-A452-63AD93A4CCF6Q28379387-F7392F6E-37D8-43C3-916D-FF0D5C7CCE0DQ29619314-5022C461-45E4-446D-B070-7B05D36C7DEEQ33181448-3730B9DC-0E92-4134-8805-576D14DAEF45Q33578241-2D8F65F3-9998-4E2C-9949-904EA43016CAQ33598817-67E85B58-09C4-4C59-B277-EE4707630EAEQ33763804-5BD3C84B-ED4B-4729-ABC8-1FB29FD033B6Q33829995-1B9A43AB-7296-40AB-896D-D7D7D06665C5Q33876035-FB91C662-206C-4C31-B8E1-25D066AF9E38Q33893613-EB667AB1-CFC4-4AE0-90E3-8EB8F7328694Q33946786-AD0D105C-7899-46F2-A613-7B11E6E4F789Q34001598-E6606323-0869-4D59-B108-BFA9CF56FF24Q34003535-516A2082-A6D5-4104-8596-C2F6F0D1D227Q34008033-3BE378FD-17E2-47BA-BF96-1D2AD3941D85Q34118627-B55FA601-BE88-4EA2-A4E0-EE19B09AE51DQ34428963-ECF3CECE-9DFD-4C24-BD02-FF04B5305687Q34536384-9CA1C9F3-1AF8-433D-B7E5-C11E9940B1A7Q34577866-A11C6233-B9C9-4C9A-92E9-86ED1A6D48A2Q35115377-57ACEECE-5E20-4E01-82DD-B25A80AB5A1BQ35134181-2C770443-79B5-45F3-AB9B-600BB7C1CD99Q35225048-FDCA33B6-5636-49B2-ADBC-985D16B8473BQ35380946-0D9DF9FC-FD3E-49E1-A7D4-44125278AFBBQ35389822-2A8EDD48-1C27-4C7B-B5AB-E4E148F92222Q35397535-276A2852-6ACB-4375-A457-95D51E2301CDQ35417709-A4FF52D1-F58A-4786-81E3-6DEC0473ECFDQ35480633-0F2BFBB0-B639-412E-A2EC-AB35B7104787Q35484895-97817B2D-B34A-408A-8D9B-DE2B301F9A27Q35546559-52D1C61E-F1EC-45B1-B466-C78ABCFE4312Q35560441-DB6358A8-FA93-4FF6-BD1C-30BBF8CAC746Q35679315-315E4EE9-A978-4F44-8CC6-C265987AF4C5Q35682162-1672B27E-92C1-487A-9CF4-69F88A2C9BD5Q35751460-0B880862-8D5E-4A6E-A1AB-24B4523657A0Q36013244-BE74C7C4-ED6A-40E4-8D1E-2B6EFFA092C4Q36304667-855ECB82-E901-4CE9-AF01-2034A8EBD108Q36362532-E4818A8C-5BB1-4C54-B1AD-377C50B3518AQ36364071-6D8B8757-12C8-4A6C-8737-D6F635DA19F5
P2860
Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Strategies of anti-cytokine mo ...... and IL-5 in clinical samples.
@ast
Strategies of anti-cytokine mo ...... and IL-5 in clinical samples.
@en
type
label
Strategies of anti-cytokine mo ...... and IL-5 in clinical samples.
@ast
Strategies of anti-cytokine mo ...... and IL-5 in clinical samples.
@en
prefLabel
Strategies of anti-cytokine mo ...... and IL-5 in clinical samples.
@ast
Strategies of anti-cytokine mo ...... and IL-5 in clinical samples.
@en
P2093
P2860
P1476
Strategies of anti-cytokine mo ...... and IL-5 in clinical samples.
@en
P2093
P2860
P356
10.1111/J.1600-065X.1992.TB01406.X
P577
1992-06-01T00:00:00Z